| Pharmaceutical Wholesale and Distribution Industry | | | | • Effects of the fee-for-service (FFS) switch |
| Outlook and Analysis 2010-2025 | | | | • European price controls and parallel trade |
| | | | | • Consolidation and integration of industry |
| - how will changes affect this crucial part of the | | | | players |
| healthcare industry? | | | | • The importation of prescription drugs into the |
| | | | | USA |
| The pharmaceutical wholesale and distribution sector | | | | • Drug counterfeiting |
| is the vital link between pharmaceutical companies | | | | • The Internet – mail order drugs and on-line |
| and pharmacies. Growing demand for drugs | | | | pharmacies |
| worldwide is driving that sector's growth. However, | | | | • The threat of Wal-Mart |
| many pressures and challenges have placed a | | | | • The three major US wholesalers – |
| premium on service and efficiency in pharma | | | | AmerisourceBergen, McKesson and Cardinal Health |
| wholesale and distribution. What are the key issues | | | | – analysis of revenues, margins and business |
| involved? Who are the major players and how do | | | | structures |
| their businesses operate? Where are the best | | | | • The three major European wholesalers – |
| opportunities to be found, and how could you unlock | | | | Alliance Boots, Celesio and the Phoenix Group – |
| these? Our new report - Pharmaceutical Wholesale | | | | analysis of revenues, margins and business structures |
| and Distribution Industry Outlook and Analysis | | | | • Direct-pharmacy (DTP) trends, advantages and |
| 2010-2025 - reveals where the most-exciting | | | | challenges |
| developments will lie from the present onwards. ( ) | | | | • Overarching analyses of the European and US |
| | | | | sectors. |
| Pharmaceutical wholesalers and distributers provide | | | | |
| an often-overlooked service to the pharma industry, | | | | Comprehensive analysis of pharmaceutical wholesale |
| healthcare providers and patients. However, that | | | | and distribution |
| sector is currently in transition. Is the traditional | | | | |
| wholesale model really in decline? If so, how would it | | | | Pharmaceutical Wholesale and Distribution Industry |
| be superseded and how rapidly? Many countries are | | | | Outlook and Analysis 2010-2025 critically examines |
| experiencing changes in the way drugs are distributed | | | | that sector through a comprehensive review of |
| to retailers. Integration, consolidation and | | | | information sources. We harness both primary and |
| disintermediation are all altering the pharma supply | | | | secondary research. This new report provides unique |
| chain. How does the sector function and what does | | | | sales forecasts and analyses of commercial drivers |
| the future hold for it and its stakeholders? Our new | | | | and restraints, including a SWOT analysis. There are |
| study provides the answers that you require. | | | | over 85 tables and figures included, as well as an |
| | | | | interview with a relevant authority. The result is a |
| In particular, Pharmaceutical Wholesale and | | | | comprehensive market- and industry-centred study, |
| Distribution Industry Outlook and Analysis 2010-2025 | | | | with detailed analyses and informed opinion to benefit |
| examines following major issues: | | | | your work. |